Related Experiment Videos
Biotechnology and the pharmaceutical industry. New cardiovascular drugs
Hypertension (Dallas, Tex. : 1979)
|November 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacological properties of angiotensin II receptor antagonists.
The Canadian journal of cardiology·1999
Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics.
Hypertension research : official journal of the Japanese Society of Hypertension·1999
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.
Proceedings of the National Academy of Sciences of the United States of America·1999
Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).
The American journal of cardiology·1996
The diversified pharmacology of angiotensin II-receptor blockade.
Blood pressure. Supplement·1996
Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
Blood pressure. Supplement·1996
Revealing Causal Proteomic Signatures of Hypertension: Systematic Insights From Proteome-Wide Mendelian Randomization.
Hypertension (Dallas, Tex. : 1979)·2026
Neurovascular Signaling in the Perivascular Space: Biophysical Principles and Disruption in Hypertension.
Hypertension (Dallas, Tex. : 1979)·2026
Intrarenal Determinants of GFR Decline During Loop Diuretic Therapy.
Hypertension (Dallas, Tex. : 1979)·2026
TSP-1 Endothelial Signaling Impairs Brain Angiogenesis in Preeclampsia.
Hypertension (Dallas, Tex. : 1979)·2026
Follistatin Alleviates Vascular Dysfunction by Reducing Oxidative Stress and Promoting Browning in Perivascular Adipose Tissue.
Hypertension (Dallas, Tex. : 1979)·2026
Glycemia, Insulin Sensitivity Markers and Arterial Stiffness: The Framingham Heart Study.
Hypertension (Dallas, Tex. : 1979)·2026
Biologic Therapy for Severe Asthma: Biomarker-Guided Precision Treatment and Immunopathological Mechanisms.
Journal of visualized experiments : JoVE·2026
Discovery and development of a bispecific antibody for the treatment of hemophilia.
Proceedings of the National Academy of Sciences of the United States of America·2026
A patient-derived missense mouse model of Kabuki syndrome 1.
Disease models & mechanisms·2026
Atogepant modulates brain connectivity in episodic migraine: a longitudinal exploratory fMRI study.
Frontiers in neurology·2026